Watanabe T, Temma Y, Okada J, Yamada E, et al. In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control. Endocr J 2021 Jan 7. doi: 10.1507/endocrj.EJ20-0620.
PMID: 33408313